Immunological factors linked to geographical variation in vaccine responses-Reference-Cited by-同舟云学术

Immunological factors linked to geographical variation in vaccine responses

Published:2023-09-28 Issue: Volume: Page:
ISSN:1474-1733
Container-title:Nature Reviews Immunology
language:en
Short-container-title:Nat Rev Immunol

Author:

van Dorst Marloes M. A. R.,Pyuza Jeremia J.,Nkurunungi Gyaviira^ORCID,Kullaya Vesla I.,Smits Hermelijn H.,Hogendoorn Pancras C. W.^ORCID,Wammes Linda J.,Everts Bart^ORCID,Elliott Alison M.^ORCID,Jochems Simon P.,Yazdanbakhsh Maria^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://www.nature.com/articles/s41577-023-00941-2.pdf

Reference198 articles.

1. Li, X., Mukandavire, C. & Cucunuba, Z. M. Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study. Lancet 397, 398–408 (2021).

2. Fine, P. E. M. Variation in protection by BCG-implications of and for heterologous immunity. Lancet 346, 1339–1345 (1995). This publication is the first to address the impact of environmental factors on variation in BCG vaccine efficacy.

3. Vesikari, T. et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 370, 1757–1763 (2007).

4. Madhi, S. A. et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N. Engl. J. Med. 362, 289–298 (2010).

5. Clark, A. et al. Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials. Lancet Infect. Dis. 19, 717–727 (2019). This publication is a meta-analysis of trials across the world showing that rotavirus vaccine efficacy and durability are lowest in countries with highest child mortality.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of previous COVID-19 exposure and vaccine type (CoronaVac, ChAdOx1 nCov-19 or BNT162b2) on antibody and cytokine (Th1 or Th2) responses;Human Vaccines & Immunotherapeutics;2024-09-09

2. Differential polyvalent passive immune protection of egg yolk antibodies (IgY) against live and inactivated Vibrio fluvialis in fish;Fish & Shellfish Immunology;2024-08

3. Animal research is not always king: researchers should explore the alternatives;Nature;2024-07-16

4. Trichinella spiralis Infection Inhibits the Efficacy of RBD Protein of SARS-CoV-2 Vaccination via Regulating Humoral and Cellular Immunity;Vaccines;2024-06-30

5. Potentiation of the axis involving pentose phosphate pathway/NADPH oxidase/reactive oxygen species drives higher IL‐10 production in monocytes of Sub‐Saharan Africans;European Journal of Immunology;2024-06-14